Evidence map›Paper›PMID 40165275›Full record

ArticleItalian journal of pediatrics2025

Risk factors for bronchiolitis obliterans development in children after Mycoplasma pneumoniae pneumonia: a retrospective study of 981 patients.

Weihan Xu, Heng Wang, Xiaohui Wen, Haiming Yang, Shunying Zhao, Jinrong Liu

Abstract read
In one paragraph

Article in Italian journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Immune dysregulation inFrontiers in immunology · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Clinical characteristics ofTranslational pediatrics · 2025
    Article
  10. Article
  11. Article
  12. Immune activation and mucin dysregulation in pediatric refractoryFrontiers in cellular and infection microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Weihan XuDepartment of Respiratory Medicine, Beijing Children'S Hospital, Capital Medical University, National Center for Children'S Health, China National Clinical Research Center of Respiratory Disease, NO.56, Nanlishi Road, Beijing, 100045, People's Republic of China.
Heng WangDepartment of Respiratory Medicine, Beijing Children'S Hospital, Capital Medical University, National Center for Children'S Health, China National Clinical Research Center of Respiratory Disease, NO.56, Nanlishi Road, Beijing, 100045, People's Republic of China.
Xiaohui WenDepartment of Respiratory Medicine, Beijing Children'S Hospital, Capital Medical University, National Center for Children'S Health, China National Clinical Research Center of Respiratory Disease, NO.56, Nanlishi Road, Beijing, 100045, People's Republic of China.
Haiming YangDepartment of Respiratory Medicine, Beijing Children'S Hospital, Capital Medical University, National Center for Children'S Health, China National Clinical Research Center of Respiratory Disease, NO.56, Nanlishi Road, Beijing, 100045, People's Republic of China.
Shunying ZhaoDepartment of Respiratory Medicine, Beijing Children'S Hospital, Capital Medical University, National Center for Children'S Health, China National Clinical Research Center of Respiratory Disease, NO.56, Nanlishi Road, Beijing, 100045, People's Republic of China. zhaoshunying2001@163.com.
Jinrong LiuDepartment of Respiratory Medicine, Beijing Children'S Hospital, Capital Medical University, National Center for Children'S Health, China National Clinical Research Center of Respiratory Disease, NO.56, Nanlishi Road, Beijing, 100045, People's Republic of China. liujinrong2006@126.com.ORCID http://orcid.org/0000-0002-6120-6999

Funding

Beijing Municipal Natural Science Foundation 7224329
6 · The paper itself

Abstract

backgroundBronchiolitis obliterans (BO) is a rare and severe chronic pulmonary condition in children following an injury to lower respiratory tract lesion. Mycoplasma pneumoniae (M. pneumoniae) is the second etiology of post-infectious bronchiolitis obliterans (PIBO). The aim of this study was to determine risk factors for PIBO development in children after M. pneumoniae pneumonia.

methodsThis retrospective study enrolled 981 children admitted to Beijing children's hospital due to M. pneumoniae pneumonia between January 2016 and December 2022. The medical records of the PIBO and non-PIBO groups, including demographic, clinical, radiologic, and laboratory data were analyzed by multivariate logistic regression to reveal PIBO development-associated risk factors.

resultsSeventy-two of the study patients developed PIBO after M. pneumoniae pneumonia. Multivariate analysis showed that large lobar consolidation (OR 4.06, 95% CI 1.18-14.03), diffuse bronchiolitis (OR 11.78, 95% CI 3.28-42.22), co-infection (OR 3.65, 95% CI 1.60-8.33), atopic conditions (OR 12.32, 95% CI 5.2-29.11), bronchial mucus plug (OR 2.48, 95% CI 1.10-5.58), CPR (OR 1.01, 95% CI 1.00-1.02), mechanical ventilation (OR 2.95, 95% CI 1.00-8.67), and duration of fever (OR 1.19, 95% CI 1.05-1.37) were significantly associated with development of PIBO after M. pneumoniae pneumonia.

conclusionsIn children with M. pneumoniae pneumonia, large lobar consolidation, diffuse bronchiolitis, co-infections, atopic conditions, bronchial mucus plug, CRP, mechanical ventilation, and duration of fever appeared as prominent independent risk factors for PIBO. Timely application of HRCT could provide a basis for the early prediction of PIBO development in children.

Indexed as

Bronchiolitis ObliteransPneumonia, MycoplasmaChildChild, PreschoolFemaleHumansInfantMaleMycoplasma pneumoniaeRetrospective StudiesRisk FactorsChildrenHRCTMycoplasma pneumoniaePost-infectious bronchiolitis ObliteransRisk factors

Identifiers

PMID40165275
PMCPMC11956267

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.